{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": "A30P",
      "variant_string_id": "SNCA A30P",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_steps": {
          "step1": {
            "judgment": "Yes",
            "reason": "The study links Cu(II) binding to R-synuclein in PD pathogenesis, and A30P is a known pathogenic variant associated with familial PD."
          },
          "step2": {
            "judgment": "Yes",
            "reason": "The Cu(II) binding assay is relevant to PD pathogenesis as described in the paper."
          },
          "step3": {
            "step3a": {
              "judgment": "Yes",
              "reason": "Wild-type R-synuclein is used as a control. Replicates are implied through multiple pH conditions and binding constant measurements."
            },
            "step3b": {
              "judgment": "Not applicable",
              "reason": "Step 3a was sufficient."
            },
            "step3c": {
              "judgment": "No",
              "reason": "No known pathogenic/benign variant controls were explicitly tested in this study."
            }
          },
          "step4": {
            "step4a": {
              "judgment": "No",
              "reason": "The study lacks explicit statistical tests (e.g., p-values) to estimate OddsPath."
            },
            "step4b": {
              "judgment": "Max PS3_supporting",
              "reason": "Only two variant controls (A30P and A53T) were used; total is less than 10."
            },
            "step4c": {
              "judgment": "Not applicable",
              "reason": "Step 4a was insufficient."
            }
          }
        },
        "strength": "PS3_supporting",
        "reason": "The study design and statistical limitations cap the strength at supporting, despite functional differences observed in A30P (e.g., dual binding sites)."
      }
    },
    {
      "gene": "SNCA",
      "protein_change": "A53T",
      "variant_string_id": "SNCA A53T",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_steps": {
          "step1": {
            "judgment": "Yes",
            "reason": "The study links Cu(II) binding to R-synuclein in PD pathogenesis, and A53T is a known pathogenic variant associated with familial PD."
          },
          "step2": {
            "judgment": "Yes",
            "reason": "The Cu(II) binding assay is relevant to PD pathogenesis as described in the paper."
          },
          "step3": {
            "step3a": {
              "judgment": "Yes",
              "reason": "Wild-type R-synuclein is used as a control. Replicates are implied through multiple pH conditions and binding constant measurements."
            },
            "step3b": {
              "judgment": "Not applicable",
              "reason": "Step 3a was sufficient."
            },
            "step3c": {
              "judgment": "No",
              "reason": "No known pathogenic/benign variant controls were explicitly tested in this study."
            }
          },
          "step4": {
            "step4a": {
              "judgment": "No",
              "reason": "The study lacks explicit statistical tests (e.g., p-values) to estimate OddsPath."
            },
            "step4b": {
              "judgment": "Max PS3_supporting",
              "reason": "Only two variant controls (A30P and A53T) were used; total is less than 10."
            },
            "step4c": {
              "judgment": "Not applicable",
              "reason": "Step 4a was insufficient."
            }
          }
        },
        "strength": "PS3_supporting",
        "reason": "The study design and statistical limitations cap the strength at supporting, despite functional similarities to WT observed in A53T."
      }
    }
  ]
}